Literature DB >> 17389013

Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.

L Beretta1, F Cappiello, M Barili, R Scorza.   

Abstract

Interleukin-10 (IL-10) can favour the development of fibrosis by promoting a relative shift towards T helper 2 responses. Three single base pair substitutions in the 5' flanking region of the IL-10 gene (G/A -1082, C/T -819 and C/A -592) influence the amount of IL-10 secreted in cell cultures: the GCC haplotype is associated with an increased production, while the ACC and the ATA haplotypes are associated with intermediate and decreased production. Accordingly, three phenotypes have been individuated: high producers (GCC+/GCC+), medium producers (GCC+/GCC-) and low producers (GCC-/GCC-). We hypothesised that IL-10 haplotypes and genotypes are differently expressed in patients with systemic sclerosis (SSc) with the limited cutaneous SSc (lcSSc) subset or the diffuse cutaneous SSc (dcSSc) subset. One hundred and sixty-one unrelated Italian patients with SSc and 94 controls have been included. Their DNA was extracted and stored before being analysed by polymerase chain reaction with sequence-specific primers. The GCC haplotype is overrepresented in patients with SSc; subjects with dcSSc were the primary contributors to these results (dcSSc: 52.2% vs controls: 37.2%; chi2= 8.519, 2 d.f., corrected P= 0.04). In Scl70-positive patients, the GCC haplotype increased the likelihood of presenting the dcSSc subset [chi2= 12.56, P < 0.0005; odds ratio (OR) = 3.89, 95% confidence interval (CI(95)) = 1.69-9.08]; these results were confirmed at the phenotypic level (chi2= 11.67, 2 d.f., P= 0.003). In Scl70-positive patients, the high-producing phenotype was associated with poor survival, independently from disease subset and gender (hazard ratio = 9.9, CI(95)= 1.6-61.27, P < 0.05). The IL-10 haplotype and genotype associated with high IL-10 production may alter the susceptibility to SSc and/or its expression, increasing the prognostic value of other well-known markers of disease severity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389013     DOI: 10.1111/j.1399-0039.2007.00811.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk.

Authors:  Wen-Jia Peng; Qian He; Jin-Xia Yang; Bing-Xiang Wang; Man-Man Lu; Song Wang; Jing Wang
Journal:  Mol Biol Rep       Date:  2011-12-09       Impact factor: 2.316

2.  Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis.

Authors:  Wen-jia Peng; Bing-xiang Wang; Hai-feng Pan; Jin-hui Tao; Jun-qing Zhang; Qian He; Chang-chun Xiao; Jing Wang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

3.  Association between 'interleukin' 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement.

Authors:  O Ates; B Müsellim; G Ongen; A Topal-Sarikaya
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

4.  Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis.

Authors:  Jadwiga Skretkowicz; Malgorzata Baranska; Mariola Rychlik-Sych
Journal:  Eur J Clin Pharmacol       Date:  2009-05-15       Impact factor: 2.953

Review 5.  Molecular genetic mechanisms of chronic urticaria.

Authors:  Purevsuren Losol; Hye-Soo Yoo; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2013-10-30       Impact factor: 5.764

6.  Cytokine gene polymorphisms are not associated with anti-PvDBP, anti-PvAMA-1 or anti-PvMSP-119 IgG antibody levels in a malaria-endemic area of the Brazilian Amazon.

Authors:  Adriana A C Furini; Marcela P Capobianco; Luciane M Storti-Melo; Maristela G Cunha; Gustavo C Cassiano; Ricardo Luiz D Machado
Journal:  Malar J       Date:  2016-07-19       Impact factor: 2.979

7.  Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.

Authors:  M R Pokeerbux; J Giovannelli; L Dauchet; L Mouthon; C Agard; J C Lega; Y Allanore; P Jego; B Bienvenu; S Berthier; A Mekinian; E Hachulla; D Launay
Journal:  Arthritis Res Ther       Date:  2019-04-03       Impact factor: 5.156

8.  No evidence for a role of the proximal IL-6 G/C -174 single nucleotide polymorphism in Italian patients with systemic sclerosis.

Authors:  Lorenzo Beretta; Alessandro Santaniello; Francesca Cappiello; Morena Barili; Raffaella Scorza
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.